ArticleCancer chemotherapy and pharmacology2021

Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approach.

Sumit Bhatnagar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.